 "Hetero")
Hyderabad-based drug major Hetero has priced the generic version of Pfizer’s Covid antiviral treatment Paxlovid at $60 for the full course in India.
However, the company would export it for a price of $70 for a course comprising 30 tablets.
The company on Monday said it has emerged the first player globally to receive World Health Organisation’s (WHO) prequalification of medicines programme (WHO-PQ) for its generic version of Covid-19 oral antiviral treatment candidate Nirmatrelvir. This, along with Ritonavir, is used as part of Pfizer’s Paxlovid.
A Hetero source indicated that the company has already started production in batches of this
